Xin Lang Cai Jing·2026-01-12 07:48Group 1 - The core viewpoint of the news is that Nocera Biopharma has seen a continuous increase in its stock price, reflecting positive market sentiment and potential investment opportunities [1] - As of January 12, Nocera Biopharma's stock price is 22.58 yuan per share, with a total market capitalization of 39.846 billion yuan and a trading volume of 2.12 billion yuan [1] - The company specializes in the research, production, and commercialization of biopharmaceuticals, focusing on unmet clinical needs in oncology and autoimmune diseases [1] Group 2 - Morgan Stanley's fund holds a significant position in Nocera Biopharma, with the Morgan Stanley Hong Kong-Shanghai Select Mixed A Fund owning 420,000 shares, representing 6.87% of the fund's net value [2] - The fund has generated a floating profit of approximately 69,720 yuan during the four-day stock price increase [2] - The Morgan Stanley Hong Kong-Shanghai Select Mixed A Fund has a total asset size of 67.3812 million yuan and has achieved a year-to-date return of 14.11% [2]